BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 950,000 Value ($000) $976 Avg Close — Range —
Q4 2022
Shares 250,000 Value ($000) $266 Avg Close — Range —
Q3 2022
Shares 461,000 Value ($000) $459 Avg Close — Range —
Q2 2022
Shares 450,000 Value ($000) $445 Avg Close — Range —
Q1 2022
Shares 450,000 Value ($000) $453 Avg Close — Range —
Q4 2021
Shares 450,000 Value ($000) $473 Avg Close — Range —
Q3 2021
Shares 850,000 Value ($000) $873 Avg Close — Range —
Q2 2021
Shares 850,000 Value ($000) $885 Avg Close — Range —
Q1 2021
Shares 850,000 Value ($000) $870 Avg Close — Range —
Q4 2020
Shares 850,000 Value ($000) $916 Avg Close — Range —
Q3 2020
Shares 850,000 Value ($000) $888 Avg Close — Range —
Q2 2020
Shares 850,000 Value ($000) $1,043 Avg Close — Range —
Q1 2020
Shares 450,000 Value ($000) $470 Avg Close — Range —
Q4 2019
Shares 858,000 Value ($000) $909 Avg Close — Range —
Q3 2019
Shares 858,000 Value ($000) $846 Avg Close — Range —
Q2 2019
Shares 858,000 Value ($000) $892 Avg Close — Range —
Q1 2019
Shares 858,000 Value ($000) $882 Avg Close — Range —
Q4 2018
Shares 850,000 Value ($000) $843 Avg Close — Range —
Q3 2018
Shares 850,000 Value ($000) $905 Avg Close — Range —